LENZ Therapeutics (LENZ) Institutional Ownership

$7.44 -0.34 (-4.37%)

Closing price 04:00 PM Eastern

Extended Trading

$7.50 +0.05 (+0.74%)

As of 07:05 PM Eastern

Compare

Current Institutional Ownership Percentage: 54.32%
Number of Institutional Buyers (last 12 months): 125
Total Institutional Inflows (last 12 months): $466.32M

Number of Institutional Sellers (last 12 months): 24
Total Institutional Outflows (last 12 months): $56.26M

Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2026	Bank of America Corp DE	547,534	$5.01M	0.0%	+377.4%	1.746%
5/18/2026	Royal Bank of Canada	95,235	$870K	0.0%	+120.6%	0.304%
5/16/2026	Quantinno Capital Management LP	47,648	$436K	0.0%	N/A	0.152%
5/15/2026	Affinity Asset Advisors LLC	100,000	$915K	0.0%	-200.0%	0.319%
5/14/2026	Knott David M Jr	33,732	$309K	0.2%	-37.2%	0.108%
5/7/2026	Dimensional Fund Advisors LP	41,874	$381K	0.0%	-63.0%	0.134%
5/7/2026	KBC Group NV	90,425	$827K	0.0%	N/A	0.288%
5/6/2026	C WorldWide Group Holding A S	700,000	$6.41M	0.1%	+40.0%	2.233%
5/5/2026	Bank of New York Mellon Corp	49,797	$456K	0.0%	+13.0%	0.159%
4/30/2026	Hsbc Holdings PLC	21,894	$204K	0.0%	N/A	0.070%
Get the Latest News and Ratings for LENZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/27/2026	Y Intercept Hong Kong Ltd	158,715	$1.45M	0.0%	+290.8%	0.506%
4/22/2026	Janney Montgomery Scott LLC	10,814	$99K	0.0%	N/A	0.034%
3/17/2026	Rockefeller Capital Management L.P.	48,071	$769K	0.0%	+167.1%	0.154%
3/3/2026	Caitong International Asset Management Co. Ltd	3,686	$59K	0.0%	N/A	0.012%
2/26/2026	Aristides Capital LLC	10,500	$168K	0.0%	N/A	0.034%
2/23/2026	Virtu Financial LLC	12,347	$198K	0.0%	N/A	0.039%
2/19/2026	Invesco Ltd.	14,046	$225K	0.0%	-96.1%	0.045%
2/18/2026	XTX Topco Ltd	85,782	$1.37M	0.0%	N/A	0.274%
2/18/2026	VARCOV Co.	78,831	$1.26M	0.5%	N/A	0.252%
2/18/2026	Vestal Point Capital LP	275,000	$4.40M	0.1%	N/A	0.879%
2/18/2026	Virtus Investment Advisers LLC	37,674	$603K	0.2%	+879.3%	0.120%
2/18/2026	Wellington Management Group LLP	54,402	$870K	0.0%	-11.3%	0.174%
2/18/2026	Tang Capital Management LLC	865,169	$13.84M	0.7%	-3.6%	2.765%
2/18/2026	Perceptive Advisors LLC	50,000	$800K	0.0%	N/A	0.160%
2/18/2026	Millennium Management LLC	539,348	$8.63M	0.0%	N/A	1.724%
2/18/2026	Engineers Gate Manager LP	31,058	$497K	0.0%	N/A	0.099%
2/17/2026	Freestone Grove Partners LP	22,971	$368K	0.0%	N/A	0.073%
2/17/2026	Trexquant Investment LP	173,183	$2.77M	0.0%	N/A	0.553%
2/17/2026	Jump Financial LLC	40,851	$654K	0.0%	N/A	0.131%
2/17/2026	Price T Rowe Associates Inc. MD	1,023,542	$16.38M	0.0%	+307.6%	3.271%
2/17/2026	Rock Springs Capital Management LP	257,460	$4.12M	0.2%	+9.0%	0.823%
2/17/2026	Russell Investments Group Ltd.	15,461	$247K	0.0%	-89.3%	0.049%
2/17/2026	Granahan Investment Management LLC	431,100	$6.90M	0.3%	+125.2%	1.378%
2/17/2026	State of Wisconsin Investment Board	32,235	$516K	0.0%	+33.7%	0.103%
2/17/2026	ExodusPoint Capital Management LP	23,147	$370K	0.0%	N/A	0.074%
2/17/2026	Royal Bank of Canada	43,172	$691K	0.0%	-10.6%	0.138%
2/17/2026	Blair William & Co. IL	10,207	$163K	0.0%	+27.7%	0.033%
2/16/2026	Squarepoint Ops LLC	491,898	$7.87M	0.0%	+447.8%	1.572%
2/16/2026	Verition Fund Management LLC	46,268	$740K	0.0%	N/A	0.148%
2/16/2026	Entropy Technologies LP	11,000	$176K	0.0%	N/A	0.035%
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
2/16/2026	Barclays PLC	72,432	$1.16M	0.0%	+51.4%	0.231%
2/13/2026	Marshall Wace LLP	35,252	$564K	0.0%	N/A	0.113%
2/13/2026	AWM Investment Company Inc.	150,000	$2.40M	0.2%	N/A	0.479%
2/13/2026	Jacobs Levy Equity Management Inc.	270,919	$4.34M	0.0%	N/A	0.866%
2/13/2026	Vivaldi Capital Management LP	64,052	$1.03M	0.1%	+23.8%	0.205%
2/13/2026	Alyeska Investment Group L.P.	463,495	$7.42M	0.0%	+91.4%	1.481%
2/13/2026	Charles Schwab Investment Management Inc.	169,122	$2.71M	0.0%	+5.4%	0.540%
2/13/2026	State Street Corp	510,749	$8.17M	0.0%	+22.2%	1.632%
2/13/2026	Caitong International Asset Management Co. Ltd	1,988	$32K	0.1%	N/A	0.006%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	18,851	$302K	0.0%	+61.2%	0.060%
2/13/2026	Wells Fargo & Company MN	22,916	$367K	0.0%	+119.3%	0.073%
2/12/2026	HRT Financial LP	171,283	$2.74M	0.0%	+484.4%	0.547%
2/12/2026	Aristides Capital LLC	10,500	$168K	0.0%	N/A	0.034%
2/12/2026	Dimensional Fund Advisors LP	113,094	$1.81M	0.0%	+176.6%	0.361%
2/12/2026	Federated Hermes Inc.	62,636	$1.00M	0.0%	N/A	0.200%
2/12/2026	Marex Group plc	16,000	$256K	0.0%	N/A	0.051%
2/12/2026	New York State Common Retirement Fund	6,693	$107K	0.0%	+49.0%	0.021%
2/12/2026	Knott David M Jr	53,732	$860K	0.4%	-34.5%	0.172%
2/12/2026	Nuveen LLC	39,905	$638K	0.0%	-86.0%	0.128%
2/11/2026	Primecap Management Co. CA	372,200	$5.96M	0.0%	N/A	1.190%
2/11/2026	Fox Run Management L.L.C.	15,739	$252K	0.0%	N/A	0.050%
2/11/2026	Franklin Resources Inc.	1,096,334	$17.54M	0.0%	+86.7%	3.504%
2/11/2026	Los Angeles Capital Management LLC	3,888	$62K	0.0%	N/A	0.012%
2/11/2026	Propel Bio Management LLC	59,085	$945K	0.8%	N/A	0.189%
2/11/2026	State of Wyoming	1,849	$30K	0.0%	N/A	0.006%
2/10/2026	TD Asset Management Inc	26,978	$432K	0.0%	-14.1%	0.086%
2/10/2026	Goldman Sachs Group Inc.	257,942	$4.13M	0.0%	+524.9%	0.824%
2/10/2026	AXQ Capital LP	19,839	$317K	0.1%	+289.2%	0.063%
2/10/2026	Nomura Asset Management Co. Ltd.	96,780	$1.55M	0.0%	+121.1%	0.309%
2/9/2026	Geode Capital Management LLC	461,075	$7.38M	0.0%	+1.4%	1.474%
2/9/2026	Sectoral Asset Management Inc.	42,500	$680K	0.5%	N/A	0.136%
2/9/2026	Blue Owl Capital Holdings LP	150,000	$2.40M	0.2%	N/A	0.479%
2/9/2026	Simplify Asset Management Inc.	17,481	$280K	0.0%	N/A	0.056%
2/5/2026	AlphaCore Capital LLC	10,000	$160K	0.0%	N/A	0.032%
2/5/2026	DNB Asset Management AS	19,163	$307K	0.0%	N/A	0.061%
2/4/2026	C WorldWide Group Holding A S	500,000	$8M	0.1%	N/A	1.598%
1/29/2026	UBS Group AG	1,571,738	$25.15M	0.0%	+30.8%	5.023%
1/29/2026	China Universal Asset Management Co. Ltd.	5,099	$82K	0.0%	-36.3%	0.016%
1/23/2026	State of Alaska Department of Revenue	19,159	$306K	0.0%	N/A	0.061%
1/20/2026	Sovran Advisors LLC	160,134	$2.56M	0.2%	+49.8%	0.512%
1/20/2026	Harbor Capital Advisors Inc.	23,921	$383K	0.0%	+63.8%	0.076%
1/16/2026	Aberdeen Group plc	489,432	$7.83M	0.0%	+274.4%	1.564%
1/1/2026	JPMorgan Chase & Co.	11,222	$523K	0.0%	+8.3%	0.036%
12/15/2025	Hudson Bay Capital Management LP	67,225	$3.13M	0.0%	+201.3%	0.215%
11/18/2025	Advisory Services Network LLC	6,421	$299K	0.0%	N/A	0.021%
11/17/2025	Vivaldi Capital Management LP	51,752	$2.41M	0.3%	-12.7%	0.165%
11/17/2025	Dark Forest Capital Management LP	10,163	$473K	0.0%	N/A	0.032%
11/17/2025	Alyeska Investment Group L.P.	242,113	$11.28M	0.0%	+11.5%	0.774%
11/17/2025	Voleon Capital Management LP	8,591	$400K	0.0%	N/A	0.027%
11/17/2025	Summit Partners Public Asset Management LLC	323,857	$15.09M	0.3%	+34.9%	1.035%
The Iran War Just Broke the Gold Market (Ad) The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000. You can see the evidence — and the ticker symbol — here >>>
11/17/2025	Quarry LP	577	$27K	0.0%	N/A	0.002%
11/17/2025	Plustick Management LLC	200,000	$9.32M	3.9%	N/A	0.639%
11/17/2025	Paradigm Biocapital Advisors LP	1,073,461	$50.00M	1.4%	-37.5%	3.431%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	7,480	$348K	0.0%	-23.3%	0.024%
11/17/2025	Granahan Investment Management LLC	191,397	$8.92M	0.4%	+4.4%	0.612%
11/17/2025	First Light Asset Management LLC	693,044	$32.28M	3.0%	N/A	2.215%
11/17/2025	Cinctive Capital Management LP	21,062	$981K	0.0%	N/A	0.067%
11/17/2025	Bank of America Corp DE	349,128	$16.26M	0.0%	+413.6%	1.116%
11/17/2025	Ally Bridge Group NY LLC	175,363	$8.17M	5.0%	-48.9%	0.560%
11/17/2025	Ameriprise Financial Inc.	55,673	$2.59M	0.0%	+3.2%	0.178%

LENZ Institutional Ownership - Frequently Asked Questions

During the previous two years, 159 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($123.76M), Vanguard Group Inc. ($61.97M), Paradigm Biocapital Advisors LP ($50.00M), Adage Capital Partners GP L.L.C. ($32.91M), First Light Asset Management LLC ($32.28M), Samsara BioCapital LLC ($28.49M), and UBS Group AG ($25.15M).Learn more on LENZ Therapeutics' institutional investors.

54.32% of LENZ Therapeutics' stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings.

Of the 150 institutional investors that purchased LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($2.66M), Paradigm Biocapital Advisors LP ($1.51M), Price T Rowe Associates Inc. MD ($1.15M), Adage Capital Partners GP L.L.C. ($1.12M), Franklin Resources Inc. ($1.09M), Bank of America Corp DE ($782.04K), and C WorldWide Group Holding A S ($700K).

Institutional investors have bought a total of 16,278,337 shares in the last 24 months. This purchase volume represents approximately $466.32M in transactions.

Of the 24 institutional investors that sold LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Paradigm Biocapital Advisors LP ($643.61K), Invesco Ltd. ($350.22K), Nuveen LLC ($245.64K), Ally Bridge Group NY LLC ($167.96K), Russell Investments Group Ltd. ($129.05K), Dimensional Fund Advisors LP ($71.22K), and Knott David M Jr ($48.27K).

Institutional investors have sold a total of 1,828,570 shares in the last 24 months. This volume of shares sold represents approximately $56.26M in transactions.

Related Companies

This page (NASDAQ:LENZ) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LENZ Therapeutics (LENZ) Institutional Ownership

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

LENZ Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LENZ Therapeutics (LENZ) Institutional Ownership

Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

LENZ Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LENZ shares?

What percentage of LENZ Therapeutics' stock is owned by institutional investors?

Which institutional investors have been buying LENZ Therapeutics' stock?

How much institutional buying is happening at LENZ Therapeutics?

Which of LENZ Therapeutics' major shareholders have been selling company stock?

How much institutional selling is happening at LENZ Therapeutics?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools